Application of New French Guidelines for Economic Evaluations- A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in France
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1266
https://www.valueinhealthjournal.com/article/S1098-3015(13)03171-9/fulltext
Title :
Application of New French Guidelines for Economic Evaluations- A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03171-9&doi=10.1016/j.jval.2013.08.1266
First page :
A523
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1114